Skip to main content
Have a personal or library account? Click to login
E-selectin, but not CRP, partially mediates the association between metabolic indices and insulin resistance in older adults: a mediation analysis Cover

E-selectin, but not CRP, partially mediates the association between metabolic indices and insulin resistance in older adults: a mediation analysis

Open Access
|Feb 2026

References

  1. Lee SH, Park SY, Choi CS. Insulin resistance: from mechanisms to therapeutic strategies. Diabetes Metab J. 2022; 46:15–37.
  2. James DE, Stöckli J, Birnbaum MJ. The aetiology and molecular landscape of insulin resistance. Nat Rev Mol Cell Biol. 2021; 22:751–71.
  3. Grant RW, Meigs JB. Should the insulin resistance syndrome be treated in the elderly? Drugs Aging. 2004; 21:141–51.
  4. Fahed M, Abou Jaoudeh MG, Merhi S, Mosleh JMB, Ghadieh R, Al Hayek S, et al. Evaluation of risk factors for insulin resistance: a cross sectional study among employees at a private university in Lebanon. BMC Endocr Disord. 2020; 20:85.
  5. Anderson AL, Harris TB, Tylavsky FA, Perry SE, Houston DK, Lee JS, et al. Dietary patterns, insulin sensitivity and inflammation in older adults. Eur J Clin Nutr. 2012; 66:18–24.
  6. Myers J, Kokkinos P, Nyelin E. Physical activity, cardiorespiratory fitness, and the metabolic syndrome. Nutrients. 2019; 11:1652. doi: 10.3390/nu11071652
  7. Rizvi AA, Rizzo M. Age-related changes in insulin resistance and muscle mass: clinical implications in obese older adults. Medicina (Kaunas). 2024; 60:1648.
  8. Chen Q, Xiong S, Ye T, Gao Y, Wang J, Li X, et al. Insulin resistance, coronary artery lesion complexity and adverse cardiovascular outcomes in patients with acute coronary syndrome. Cardiovasc Diabetol. 2024; 23:172.
  9. Colantoni A, Bucci T, Cocomello N, Angelico F, Ettorre E, Pastori D, et al. Lipid-based insulin-resistance markers predict cardiovascular events in metabolic dysfunction associated steatotic liver disease. Cardiovasc Diabetol. 2024; 23:175.
  10. Son TK, Toan NH, Thang N, Le Trong Tuong H, Tien HA, et al. Prediabetes and insulin resistance in a population of patients with heart failure and reduced or preserved ejection fraction but without diabetes, overweight or hypertension. Cardiovasc Diabetol. 2022; 21:75.
  11. Hong S, Han K, Park CY. The insulin resistance by triglyceride glucose index and risk for dementia: population-based study. Alzheimers Res Ther. 2021; 13:9.
  12. Yan Y, Zhou L, La R, Jiang M, Jiang D, Huang L, et al. The association between triglyceride glucose index and arthritis: a population-based study. Lipids Health Dis. 2023; 22:132. Erratum in: Lipids Health Dis. 2024; 23:60.
  13. Chan AA, Li H, Li W, Pan K, Yee JK, Chlebowski RT, et al. Association between baseline insulin resistance and psoriasis incidence: the Women's Health Initiative. Arch Dermatol Res. 2022; 314:869–80.
  14. de Luca C, Olefsky JM. Inflammation and insulin resistance. FEBS Lett. 2008; 582:97–105.
  15. Muniyappa R, Iantorno M, Quon MJ. An integrated view of insulin resistance and endothelial dysfunction. Endocrinol Metab Clin North Am. 2008; 37:685.
  16. Pinkney JH, Stehouwer CD, Coppack SW, Yudkin JS. Endothelial dysfunction: cause of the insulin resistance syndrome. Diabetes. 1997; 46(Suppl 2):S9–13.
  17. Adamska A, Karczewska-Kupczewska M, Nikołajuk A, Otziomek E, Górska M, Kowalska I, et al. Relationships of serum soluble E-selectin concentration with insulin sensitivity and metabolic flexibility in lean and obese women. Endocrine. 2014; 45:422–9.
  18. Taniguchi A, Fukushima M, Nakai Y, Kuroe A, Yamano G, Yanagawa T, et al. Soluble E-selectin, leptin, triglycerides, and insulin resistance in nonobese Japanese type 2 diabetic patients. Metabolism. 2005; 54:376–80.
  19. Xi L, Xiao C, Bandsma RH, Naples M, Adeli K, Lewis GF. C-reactive protein impairs hepatic insulin sensitivity and insulin signaling in rats: role of mitogen-activated protein kinases. Hepatology. 2011; 53:127–35.
  20. Marnell L, Mold C, Du Clos TW. C-reactive protein: ligands, receptors and role in inflammation. Clin Immunol. 2005; 117:104–11.
  21. Thompson AM, Zhang Y, Tong W, Xu T, Chen J, Zhao L, et al. Association of obesity and biomarkers of inflammation and endothelial dysfunction in adults in Inner Mongolia, China. Int J Cardiol. 2011; 150:247–52.
  22. Ryff CD, Seeman TE, Weinstein M. Midlife in the United States (MIDUS 3): Biomarker Project, 2017–2022 [dataset]. Ann Arbor (MI): Inter-university Consortium for Political and Social Research; 2023 Mar. [cited 2025 Nov 14]. Available from: https://www.icpsr.umich.edu/web/NACDA/studies/38837.
  23. Song Y, Manson JE, Tinker L, Rifai N, Cook NR, Hu FB, et al. Circulating levels of endothelial adhesion molecules and risk of diabetes in an ethnically diverse cohort of women. Diabetes. 2007; 56:1898–904.
  24. Mathur R, Ahmid Z, Ashor AW, Shannon O, Stephan BCM, Siervo M. Effects of dietary-based weight loss interventions on biomarkers of endothelial function: a systematic review and meta-analysis. Eur J Clin Nutr. 2023; 77:927–40.
  25. Abd El-Kader SM, Al-Jiffri OH. Impact of weight reduction on insulin resistance, adhesive molecules and adipokines dysregulation among obese type 2 diabetic patients. Afr Health Sci. 2018; 18:873–83.
  26. Weber KS, Nowotny B, Strassburger K, Pacini G, Müssig K, Szendroedi J. GDS Group. The role of markers of low-grade inflammation for the early time course of glycemic control, glucose disappearance rate, and β-cell function in recently diagnosed type 1 and type 2 diabetes. Diabetes Care. 2015; 38:1758–67.
  27. Kim JA, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation. 2006; 113:1888–904.
  28. Zhang J, Huang S, Zhu Z, Gatt A, Liu J. E-selectin in vascular pathophysiology. Front Immunol. 2024; 15:1401399.
  29. Wang G, Liu Y, Wang A, Tong W, Zhang Y. Biomarkers of inflammation, endothelial dysfunction and insulin resistance in adults of Inner Mongolia, China. Diabetes Metab Res Rev. 2010; 26:490–5.
  30. Fargnoli JL, Fung TT, Olenczuk DM, Chamberland JP, Hu FB, Mantzoros CS. Adherence to healthy eating patterns is associated with higher circulating total and high-molecular-weight adiponectin and lower resistin concentrations in women from the Nurses' Health Study. Am J Clin Nutr. 2008; 88:1213–24.
  31. Brunner H, Cockcroft JR, Deanfield J, Donald A, Ferrannini E, Halcox J. Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. Endothelial function and dysfunction. Part II: association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J Hypertens. 2005; 23:233–46.
  32. Kumboyono K, Nurwidyaningtyas W, Chomsy IN, Wihastuti TA. Early detection of negative smoking impacts: vascular adaptation deviation based on quantification of circulated endothelial activation markers. Vasc Health Risk Manag. 2021; 17:103–9.
  33. Nash MC, Wade AM, Shah V, Dillon MJ. Normal levels of soluble E-selectin, soluble intercellular adhesion molecule-1 (sICAM-1), and soluble vascular cell adhesion molecule-1 (sVCAM-1) decrease with age. Clin Exp Immunol. 1996; 103:167–70.
  34. Benites-Zapata VA, Toro-Huamanchumo CJ, Urrunaga-Pastor D, Guarnizo-Poma M, Lazaro-Alcantara H, Paico-Palacios S. Insulin Resistance and Metabolic Syndrome Research Group. High waist-to-hip ratio levels are associated with insulin resistance markers in normal-weight women. Diabetes Metab Syndr. 2019; 13:636–42.
  35. Yang XY, Shao MJ, Zhou Q, Xia Y, Zou HQ. Association of waist-to-hip ratio with insulin resistance in non-diabetic normal-weight individuals: a cross-sectional study. Nan Fang Yi Ke Da Xue Xue Bao. 2017; 37:1540–4.
  36. Song Y, Yang SK, Kim J, Lee DC. Association between C-reactive protein and metabolic syndrome in Korean adults. Korean J Fam Med. 2019; 40:116–23.
  37. Kim JH, Bachmann RA, Chen J. Interleukin-6 and insulin resistance. Vitam Horm. 2009; 80:613–33.
  38. Tack CJ, Stienstra R, Joosten LA, Netea MG. Inflammation links excess fat to insulin resistance: the role of the interleukin-1 family. Immunol Rev. 2012; 249:239–52.
  39. Akash MSH, Rehman K, Liaqat A. Tumor necrosis factor-alpha: role in development of insulin resistance and pathogenesis of type 2 diabetes mellitus. J Cell Biochem. 2018; 119:105–10.
  40. Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018; 9:754.
  41. Zelicha H, Kloting N, Kaplan A, Yaskolka Meir A, Rinott E, Tsaban G, et al. The effect of high-polyphenol Mediterranean diet on visceral adiposity: the DIRECT PLUS randomized controlled trial. BMC Med. 2022; 20:327.
  42. Mons U, Müezzinler A, Gellert C, Schöttker B, Abnet CC, Bobak M, et al. Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium. BMJ. 2015; 350:h1551.
  43. Serra-Prat M, Terradellas M, Lorenzo I, Arús M, Burdoy E, Salietti A, et al. Effectiveness of a weight-loss intervention in preventing frailty and functional decline in community-dwelling obese older people: a randomized controlled trial. J Frailty Aging. 2022; 11:91–9.
  44. Rao C, Liu B, Huang D, Chen R, Huang K, Li F, et al. Nucleophosmin contributes to vascular inflammation and endothelial dysfunction in atherosclerosis progression. J Thorac Cardiovasc Surg. 2021; 161:e377–93.
  45. Zinellu A, Mangoni AA. Systematic review and meta-analysis of the effect of statins on circulating E-selectin, L-selectin, and P-selectin. Biomedicines. 2021; 9:1707.
  46. Schalkwijk CG, Smulders RA, Lambert J, Donker AJ, Stehouwer CD. ACE-inhibition modulates some endothelial functions in healthy subjects and in normotensive type 1 diabetic patients. Eur J Clin Invest. 2000; 30:853–60.
  47. Hwang YS, Tsai WC, Lu YH, Lin CC, Tsai KY. Effects of angiotensin II-receptor blockers on soluble cell adhesion molecule levels in uncomplicated systemic hypertension: an observational, controlled pilot study in Taiwanese adults. Curr Ther Res Clin Exp. 2005; 66:181–94.
  48. Yao J, Fan S, Shi X, Gong X, Zhao J, Fan G. Angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers on insulin sensitivity in hypertensive patients: a meta-analysis of randomized controlled trials. PLoS One. 2021; 16:e0253492.
  49. Wang R, Ye H, Zhao Y, Wei J, Wang Y, Zhang X, et al. Effect of sacubitril/valsartan and ACEI/ARB on glycaemia and the development of diabetes: a systematic review and meta-analysis of randomised controlled trials. BMC Med. 2022; 20:487.
  50. Xu B, Wu Q, Yin G, Lu L, La R, Zhang Y, et al. Associations of cardiometabolic index with diabetic statuses and insulin resistance: the mediating role of inflammation-related indicators. BMC Public Health. 2024; 24:2736.
DOI: https://doi.org/10.2478/abm-2026-0007 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415
Language: English
Page range: 60 - 69
Published on: Feb 27, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2026 Laith Ashour, Tariq Albweitel, Juana Abu Rahmeh, Momen Alfawadleh, Afaf El Sharabi, Rahmah Ahmad Shareah, Zaid Alomari, Arar Alhawwari, Mohammad Alkalouti, Noura F. Al-Nawaiseh, Malak S. Ababneh, Abdelrahman Kaoukji, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution 4.0 License.